Stock Events

Stock Events

CDT Equity 

0
72
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-Profit Margin
Unprofitable
2021
2022
2023
2024
2025
0Revenue
-33.78MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ZK71.F. It's not an investment recommendation.
NVIDIA
9
NVDA
Tesla
7
TSLA
Amazon
6
AMZN
AMD
6
AMD

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap173.95B
Pfizer is a major player in the pharmaceutical industry, directly competing in several therapeutic areas that Conduit Pharmaceuticals targets.
Merck
MRK
Mkt Cap368.89B
Merck operates globally in various pharmaceutical sectors, including those where Conduit Pharmaceuticals has significant investments.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson offers a wide range of pharmaceutical products that compete across multiple segments with Conduit Pharmaceuticals.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie competes in the biopharmaceutical field, particularly in areas like immunology and oncology, overlapping with Conduit's interests.
AMGEN
AMGN
Mkt Cap251.94B
Amgen focuses on biotechnological medicines, including treatments in areas where Conduit Pharmaceuticals is actively researching.
Bristol-Myers Squibb
BMY
Mkt Cap127.71B
Bristol-Myers Squibb has a strong portfolio in areas like cancer and cardiovascular diseases, directly competing with Conduit's product lines.
Gilead Sciences
GILD
Mkt Cap211.7B
Gilead Sciences specializes in antiviral drugs and other areas that are key focus points for Conduit Pharmaceuticals.
Novartis
NVS
Mkt Cap303.67B
Novartis is a global healthcare company that produces drugs in direct competition with several of Conduit Pharmaceuticals' products.
Sanofi
SNY
Mkt Cap106.24B
Sanofi operates globally, offering drugs that compete in the same categories as Conduit Pharmaceuticals.
Lilly(Eli) &
LLY
Mkt Cap1.26T
Eli Lilly and Company is involved in pharmaceutical development in areas like diabetes and cancer, competing with Conduit Pharmaceuticals.

About

CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets.
Show More
CEO
Employees
4
Country
United States
ISIN
US20678X7003
WKN
000A42NKZ

Listings

F
DE
ZK71.F
BOATS
BOATS
CDT.BOATS
XNAS
US
CDT
XNAS
US
CDTTW

0 Comments

Share your thoughts

FAQs

What is CDT Equity stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Frankfurt Exchange exchange CDT Equity stocks are traded under the ticker ZK71.F.
What is CDT Equity revenue for the last year?▼
CDT Equity revenue for the last year amounts to 0 EUR.
What is CDT Equity net income for the last year?▼
ZK71.F net income for the last year is -33.78M EUR.
How many employees does CDT Equity have?▼
As of November 2, 2026, the company has 4 employees.
In which sector is CDT Equity located?▼
CDT Equity operates in the Other sector.
When did CDT Equity complete a stock split?▼
The last stock split for CDT Equity was on September 29, 2026 with a ratio of 1:25.
Where is CDT Equity headquartered?▼
CDT Equity is headquartered in NAPLES, United States.